Bellevue (WA) – DRVISION Technologies LLC, a pioneer in computer vision, the world’s leading AI microscopy software company and the creator of Aivia has been issued two new US patents covering novel methods to train and apply machine learning models. AI based solutions continue to revolutionize all aspects of life including image-based discovery. Over the last […]

The FluidFM® BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise WALTHAM, Mass.— Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community’s growing need for next-generation single-cell and CRISPR genetic […]

The FluidFM® BOT BIO Series combines Olympus’ renowned optics with Cytosurge’s cell manipulation expertise  Waltham, Mass. & Zurich: Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community’s growing need for next-generation single-cell and CRISPR […]

SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Erin Smith to the newly created position of senior vice president of government affairs and public policy. “With the government and legislative landscape […]

Researchers at University of Pennsylvania Perelman School of Medicine and Charité University Hospitals, Berlin recognized for cutting edge work in autoimmune diseasesTUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced Vinodh Pillai, M.D., Ph.D., Assistant Professor of Pathology and Laboratory Medicine at […]

SAN DIEGO — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the emergence of the COVID-19 outbreak, Exonbio has developed a comprehensive portfolio of SARS-CoV-2 recombinant rabbit antibodies using its proprietary Single Plasma cell INterrogation (SPIN®) platform. […]

ANN ARBOR, Mich. — Swift Biosciences, Inc., a leader in the commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has signed an agreement to supply its Swift 2S® Turbo DNA Library Kits to Otogenetics Corporation, a high throughput NGS clinical lab offering Prenatal Testing, Deafness Testing, Hereditary Cancer Risk Assessment, clinical exome, […]

CAMBRIDGE, MA – Ultivue, Inc. today announced a collaborative partnership with OracleBio to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. The deal connects the histopathology image analysis expertise of OracleBio and the tissue staining capabilities of Ultivue, with the goal of providing […]

CAMBRIDGE, Mass.– Ultivue, Inc. today announced a collaborative partnership with OracleBio to help further insights and advance personalized tumor characterization in translational and clinical oncology research and drug development using multiplex immunofluorescence staining and imaging. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200722005492/en/ The deal connects the histopathology image analysis expertise of OracleBio and […]

— Includes SARS-CoV-2 Synthetic RNA Control with D614G Mutation — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of its infectious disease product line with the addition of 16 new synthetic controls […]